Jun 30, 2022

Entrada Therapeutics Q2 2022 Earnings Report

EPS
-$0.74
Previous year: -$7.49
-90.1%
Cash and Equivalents
$90.9M
Previous year: $137M
-33.6%
Free Cash Flow
-$18.8M
Previous year: -$9.45M
+98.7%
Total Assets
$296M

Entrada Therapeutics

Entrada Therapeutics